Chronic kidney disease, proteinuria, and mortality risk in patients with Parkinson’s disease: A longitudinal study
Objective: To investigate whether chronic kidney disease (CKD) and proteinuria are associated with mortality rates in patients with Parkinson's disease (PD), using data from a large…A Prospective, Observational Study to Identify Biomarkers in Parkinsonian Syndromes (proATYP).
Objective: This is a prospective observational study to identify biomarkers in parkinsonian syndromes. Background: Parkinson’s disease (PD) and atypical parkinsonian syndromes namely progressive supranuclear palsy…Secular trends and survival of Parkinson’s disease and other forms of parkinsonism in the United Kingdom
Objective: We examined the UK incidence, prevalence and survival for eight parkinsonian disorders including Parkinson’s disease (PD) from 2003 to 2023, using primary and secondary…Early-onset levodopa-responsive parkinsonism with cognitive impairment and head-bobbing dyskinesias associated with SYNJ1 and GBA variants of unknown significance
Objective: Describe the clinical and diagnostic findings of a patient with early-onset Parkinson’s Disease (EOPD) with homozygous variant of unknown significance (VUS) in the SYNJ1…A Case of Mitochondrial Membraine Protein-Associated Neurodegeneration with Progressive Parkinsonism in a Young Male
Objective: N/a Background: Less than a hundred cases of mitochondrial membrane protein-associated neurodegeneration (MPAN) have been reported thus far in literature. We present a case…Diverse clinical phenotypes of ATP1A3 mutations-A case series of four patients
Objective: To study the clinical phenotype of all patients with ATP 1A3 mutation in the genetic study Background: ATP1A3 is associated with a broad spectrum…Stepping backwards to move forward A case study on novel PT interventions for DLB
Objective: Explore the effectiveness of backwards walking and backwards stepping interventions to improve gait stability and balance in persons with Dementia with Lewy Bodies (DLB).…4R-TAU seed amplification assay discriminates tauopathies from non-tauopathies and CBD from PSP in post-mortem brain samples
Objective: To investigate whether 4R-TAU seed amplification assay discriminates tauopathies from non-tauopathies as well as CBD from PSP in post-mortem brain samples. Background: 4 repeat…Neurogenic bladder and affective disorders in parkinsonism
Objective: To determine the relationship between psychoemotional and dysuria dysfunctions in patients with PD and MSA. Background: In the group of patients with extrapyramidal pathology…Unraveling Functional Overlay in Parkinson’s Disease: A Diagnostic Challenge
Objective: To highlight the diagnostic complexities of functional movement disorders (FMD) in Parkinson’s disease (PD) and the role of neurophysiological studies in differentiating functional overlay…
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 405
- Next Page »
